* Note: Prices are in Million (M) USD.
Description:
These criteria used Company's Cash, EBITDA and Debt balance to determines its fair value:
Cash : $73 M
Debt : $605 M
EBITDA : $212 M
Net Debt (Debt - Cash): $532 M
Since Net Debt is covered by EBITDA within 3 years, 1 points assigned.
This criteria used industry in which company operates:
Sector: Health care
Industry: Medical care facilities
Based on industry, 3 points assigned.
This criteria used Company's Price To Earning (P/E) Ratio to determines its fair value:
Forward PE Ratio: 8.14
Since Forward PE Ratio is less than 15, 5 points assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Using last 3 overlapping fiscal years (max 20).Average Free Cash Flow: $7 M
Average Revenue: $2,233 M
Revenue Converted To Free Cash Flow (%): 0.3%
Since Free Cash Flow (FCF) to Revenue percentage is less than 15, 1 point assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2023-12-31): $3,111 M
Revenue 2 Years Ago (2021-12-31): $1,167 M
Total Growth over 2 Years: 166.7%
2-Year Revenue CAGR (Historical): 63.3%
Forward 5-Year CAGR (Tapered): 31.7%
Since historical Revenue CAGR is greater than 20, 5 points assigned.
This criteria used Company's ability to buy back its own share:
Error: This stock does not have 5 years of share count data.Using default values for calculation.
Based on default values, 0 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Next Year Earnings Per Share (EPS): $1.86
Trailing 12-Month Earnings Per Share (EPS): $1.53
Average Earnings Per Share (EPS): $1.69
Dividend Per Share (DPS): $0
Payout Ratio: 0%
Dividend Yield: 0%
Since Dividend Per Share is less than or equal to 0, 0 point assigned.
Since Dividend Yield is less than 1, 0 point assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Insufficient valid ROE years (found 2; need ≥ 3). Dropping ROE-based PE.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $13.77
52-Week Low: $8.28
Threshold Price (15% Above 52-Week Low): $9.52
Since Current price is not within 15% threshold, 0 point assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $1,806 M
Since Market Cap is less than 10B, 1 point assigned.
% Exposure to Total Portfolio
Based on the market cap, we recommend do not exceed 2% exposure of Total Portfolio.
Warren Buffett's Owners' Earnings:
No positive free cash flow found (TTM or annual) to compute Owners' Earnings per share.
Note: Many fast-growing companies reinvest heavily, so Owners' Earnings may appear low.
Consider other factors in your valuation.
Value-Trade has assigned 16 points to above PACS Group, Inc. (PACS) stock.
Heads up: One or more P/E inputs look exaggerated and may skew the blend.
• Growth Based PE
50.00 (>2× median)
Further research is recommended; please use your own due diligence.In such cases, multiplying earnings by the long-run average P/E typically gives a closer, more reliable fair value.
Rule of thumb: Last 1 Years Avg P/E (15.99)
× EPS ($1.69) = $27.06.
Last 1 Years Avg PE
15.99, Fair Value PE
12, Industry Based PE
15, Growth Based PE
50, RCFC Based PE
0.32, Risk-Free Anchored PE (25% MoS)
18.2. Based on these 6 values, average assigned is
18.59. Value-Trades has assined P/E value
15.99. An average (Current Year EPS + Next Year EPS) earning per share is
$1.6925.
Note: Final fair value is the lesser of the blended PE-based fair value and the simple average PE × EPS fair value.Fair value using multiple P/Es (blended): $31.46 (PE 18.59 × EPS $1.69)
Fair value using simple average PE × EPS: $27.06 (PE 15.99 × EPS $1.69)
Lesser of these two: $27.06
So the Final Fair Value is: $27.06
Understanding the Value-Trades P/E Blend (click to expand)
▾
What goes into the blended P/E?
- 20-Year Avg P/E — Long-run market baseline; conservative anchor.
- Fair Value P/E — Score-based (cash, debt, sector, etc.).
- Industry P/E — Peer group norm.
- Growth-Based P/E — Uses tapered growth rates, floored at 15.
- RCFC-Based P/E — Maps cash conversion efficiency.
- ROE-Based P/E — Higher ROE supports higher multiples.
- Risk-Free Anchored P/E — Macro floor tied to 10y yield w/ MoS.
How it works
- Extreme values are clamped/filtered (IQR method).
- Anchors (20y avg, RCFC/ROE, risk-free) are always kept if valid.
- Final fair value = min(Blended PE × EPS, Avg PE × EPS).
P/E Reference Summary
Using EPS: $1.69
| Source |
P/E Ratio |
Implied Fair Value |
| Market (1 Yr Ago) | 15.99 | $27.06 |
| 1 Yrs Avg-PE | 15.99 | $27.06 |
| Value-Trades Assigned | 15.99 | $27.06 |
Note: Only 1 years of reliable P/E data available. Fair value is calculated using blended models to reduce bias.
